Skip to main content
SpringerLink
Log in

Management of Patients with Posterior Uveal Melanoma

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

Abstract

The management of patients with posterior uveal melanoma involves detection, diagnosis, treatment, prognostication, counseling, surveillance, and, in some cases, treatment for metastatic disease. Each of these activities is advancing rapidly; however, many aspects of care remain controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Damato B. Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - a personal view. Prog Retin Eye Res. 2018;66:187.

    Article  PubMed  Google Scholar 

  2. Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119:1582–9.

    Article  PubMed  Google Scholar 

  3. Bove R, Char DH. Nondiagnosed uveal melanomas. Ophthalmology. 2004;111:554–7.

    Article  PubMed  Google Scholar 

  4. Eskelin S, Kivela T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol. 2002;86:333–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Afshar AR, Deiner M, Allen G, et al. The patient’s experience of ocular melanoma in the US: a survey of the ocular melanoma foundation. Ocul Oncol Pathol. 2018;4:280–90.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Damato BE. Tumour fluorescence and tumour-associated fluorescence of choroidal melanomas. Eye. 1992;6(Pt 6):587–93.

    Article  PubMed  Google Scholar 

  7. Callejo SA, Dopierala J, Coupland SE, et al. Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol. 2011;129:958–60.

    Article  PubMed  Google Scholar 

  8. Sen J, Groenewald C, Hiscott PS, et al. Transretinal choroidal tumor biopsy with a 25-gauge vitrector. Ophthalmology. 2006;113:1028–31.

    Article  PubMed  Google Scholar 

  9. Kivela TT, Piperno-Neumann S, Desjardins L, et al. Validation of a prognostic staging for metastatic uveal melanoma: a collaborative Study of the European Ophthalmic Oncology Group. Am J Ophthalmol. 2016;168:217–26.

    Article  PubMed  Google Scholar 

  10. Feinstein EG, Marr BP, Winston CB, et al. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Arch Ophthalmol. 2010;128:319–23.

    Article  PubMed  Google Scholar 

  11. Damato B, Heimann H. Personalized treatment of uveal melanoma. Eye. 2013;27:172–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651–9.

    Article  PubMed  Google Scholar 

  13. Damato BE, Heimann H, Kalirai H, et al. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 2014;132:605–13.

    Article  PubMed  Google Scholar 

  14. Collaborative Ocular Melanoma Study G. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–93.

    Article  Google Scholar 

  15. Damato B. Legacy of the collaborative ocular melanoma study. Arch Ophthalmol. 2007;125:966–8.

    Article  PubMed  Google Scholar 

  16. Gragoudas ES, Lane AM, Munzenrider J, et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002;100:43–8; discussion 48–49.

    PubMed  PubMed Central  Google Scholar 

  17. Karlsson UL, Augsburger JJ, Shields JA, et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology. 1989;96:382–8.

    Article  CAS  PubMed  Google Scholar 

  18. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111:977–83.

    Article  PubMed  Google Scholar 

  19. Stannard C, Sauerwein W, Maree G, et al. Radiotherapy for ocular tumours. Eye. 2013;27:119–27.

    Article  CAS  PubMed  Google Scholar 

  20. Reichstein D, Karan K. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications. Curr Opin Ophthalmol. 2018;29:191–8.

    Article  PubMed  Google Scholar 

  21. Russo A, Laguardia M, Damato B. Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2012;250:1533–40.

    Article  PubMed  Google Scholar 

  22. Astrahan MA, Luxton G, Jozsef G, et al. An interactive treatment planning system for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18:679–87.

    Article  CAS  PubMed  Google Scholar 

  23. Le BHA, Kim JW, Deng H, et al. Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review. Brachytherapy. 2018;17:981–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Konstantinidis L, Roberts D, Errington RD, et al. Transpalpebral proton beam radiotherapy of choroidal melanoma. Br J Ophthalmol. 2015;99:232–5.

    Article  PubMed  Google Scholar 

  25. Daftari IK, Char DH, Verhey LJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39:997–1010.

    Article  CAS  PubMed  Google Scholar 

  26. Damato BE, Stewart JM, Afshar AR, et al. Surgical resection of choroidal melanoma. In: Schachat AP, editor. Ryan’s retina, vol. 3. Philadelphia: Elsevier; 2018. p. 2591–600.

    Google Scholar 

  27. Konstantinidis L, Groenewald C, Coupland SE, et al. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Br J Ophthalmol. 2014;98:775–9.

    Article  PubMed  Google Scholar 

  28. Reichstein D. Current treatments and preventive strategies for radiation retinopathy. Curr Opin Ophthalmol. 2015;26:157–66.

    Article  PubMed  Google Scholar 

  29. Matet A, Daruich A, Zografos L. Radiation maculopathy after proton beam therapy for uveal melanoma: optical coherence tomography angiography alterations influencing visual acuity. Invest Ophthalmol Vis Sci. 2017;58:3851–61.

    Article  PubMed  Google Scholar 

  30. Zehetmayer M. Stereotactic photon beam irradiation of uveal melanoma. Dev Ophthalmol. 2012;49:58–65.

    Article  PubMed  Google Scholar 

  31. Schilling H, Bornfeld N, Talies S, et al. [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife--first experience on 46 cases]. Klinische Monatsblatter fur Augenheilkunde. 2006;223:513–20.

    Article  CAS  PubMed  Google Scholar 

  32. Journee-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM, et al. Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol. 1992;82:185–91.

    Article  CAS  PubMed  Google Scholar 

  33. Shields CL, Shields JA, Perez N, et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002;109:225–34.

    Article  PubMed  Google Scholar 

  34. Damato B. Vasculopathy after treatment of choroidal melanoma. In: Joussen A, Gardner TW, Kirchhof B, Ryan SJ, editors. Retinal vascular disease. Berlin: Springer; 2007. p. 582–91.

    Chapter  Google Scholar 

  35. Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013;27:163–71.

    Article  CAS  PubMed  Google Scholar 

  36. Jmor F, Hussain RN, Damato BE, et al. Photodynamic therapy as initial treatment for small choroidal melanomas. Photodiagn Photodyn Ther. 2017;20:175–81.

    Article  CAS  Google Scholar 

  37. Kines RC, Varsavsky I, Choudhary S, et al. An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma. Mol Cancer Ther. 2018;17:565–74.

    Article  CAS  PubMed  Google Scholar 

  38. Wilson DJ, Klein ML. Cryotherapy as a primary treatment for choroidal melanoma. Arch Ophthalmol. 2002;120:400–3.

    PubMed  Google Scholar 

  39. Konstantinidis L, Groenewald C, Coupland SE, et al. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol. 2014;98:82–5.

    Article  PubMed  Google Scholar 

  40. Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol. 2008;92:1013–4.

    Article  PubMed  Google Scholar 

  41. Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin. 2006;46:95–107.

    Article  PubMed  Google Scholar 

  42. Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Damato B, Eleuteri A, Taktak AF, et al. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30:285–95.

    Article  PubMed  Google Scholar 

  44. Berry D, Seider M, Stinnett S, et al. Relationship of clinical features and baseline tumor size with gene expression profile status in uveal melanoma: a multi-institutional Study. Retina. 2018.

    Google Scholar 

  45. Vaquero-Garcia J, Lalonde E, Ewens KG, et al. PRiMeUM: a model for predicting risk of metastasis in uveal melanoma. Invest Ophthalmol Vis Sci. 2017;58:4096–105.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Hussain RN, Kalirai H, Groenewald C, et al. Prognostic biopsy of choroidal melanoma after proton beam radiation therapy. Ophthalmology. 2016;123:2264–5.

    Article  PubMed  Google Scholar 

  47. Eskelin S, Pyrhonen S, Summanen P, et al. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85:1151–9.

    Article  CAS  PubMed  Google Scholar 

  48. Marshall E, Romaniuk C, Ghaneh P, et al. MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol. 2013;97:159–63.

    Article  PubMed  Google Scholar 

  49. Wen JC, Sai V, Straatsma BR, et al. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma. JAMA Ophthalmol. 2013;131:56–61.

    Article  PubMed  Google Scholar 

  50. Patel P, Finger PT. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis. Am J Ophthalmol. 2012;153:661–8.

    Article  PubMed  Google Scholar 

  51. Strobel K, Bode B, Dummer R, et al. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging. 2009;36:1774–82.

    Article  CAS  PubMed  Google Scholar 

  52. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:2438–44.

    Article  Google Scholar 

  53. Augsburger JJ, Correa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011;152:5–9 e1.

    Article  PubMed  Google Scholar 

  54. Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010;128:871–5.

    Article  PubMed  Google Scholar 

  55. Komatsubara KM, Carvajal RD. Immunotherapy for the treatment of uveal melanoma: current status and emerging therapies. Curr Oncol Rep. 2017;19:45.

    Article  PubMed  Google Scholar 

  56. Whitehead J, Tishkovskaya S, O’Connor J, et al. Devising two-stage and multistage phase II studies on systemic adjuvant therapy for uveal melanoma. Invest Ophthalmol Vis Sci. 2012;53:4986–9.

    Article  CAS  PubMed  Google Scholar 

  57. Damato B, Hope-Stone L, Cooper B, et al. Patient-reported outcomes and quality of life after treatment of choroidal melanoma: a comparison of enucleation vs radiotherapy in 1596 patients. Am J Ophthalmol. 2018;193:230.

    Article  PubMed  Google Scholar 

  58. Ah-Fat FG, Sharma MC, Damato BE. Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy. Eye. 1998;12(Pt 5):789–91.

    Article  PubMed  Google Scholar 

  59. Yang J, Manson DK, Marr BP, et al. Treatment of uveal melanoma: where are we now? Ther Adv Med Oncol. 2018;10:1758834018757175.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK

    Bertil E. Damato

Authors
  1. Bertil E. Damato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bertil E. Damato .

Editor information

Editors and Affiliations

  1. University of Oxford, Oxford, UK

    Bertil E. Damato

  2. Cole Eye Institute Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Damato, B.E. (2019). Management of Patients with Posterior Uveal Melanoma. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-17879-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17879-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17878-9

  • Online ISBN: 978-3-030-17879-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation